Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
clinical trials
fda
indiana blog main
indiana top stories
life sciences
national blog main
raleigh-durham blog main
raleigh-durham top stories
aimmune therapeutics
allergy
alprazolam
amgen
anaphylaxis
andrew oxtoby
boston top stories
boulder/denver blog main
boulder/denver top stories
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
daniel edelman
detroit blog main
detroit top stories
drug enforcement administration
eli lilly
eosinophilic esophagitis
food allergy
immunotherapy
indiana
jayson dallas
lasmiditan
medicaid
migraine research foundation
national top stories
new york blog main
new york top stories
palforzia
san diego blog main
What
approval
drug
fda
friday
2
×
won
2
×
acute
addresses
agency
aimmune
allergy
approved
awarded
causes
condition
decades
developed
eli
giant
giving
immunotherapy
lasmiditan
late
lilly
lilly’s
medication
migraine
new
oks
oral
peanut
pharmaceutical
second
therapeutics
therapy
time
treat
Language
unset
Current search:
won���t
×
friday
×
won
×
biotech
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades